...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zhlcf

And if that is not enough, they are even shorting it.

Short Interest:

Date
Short Interest
% Change
AVG. Daily Share Vol
Days to Cover
Split
New Issue
11/30/2020 34,535 0.00 14,684 2.35 No No
11/13/2020 34,535 0.00 15,088 2.29 No No
10/30/2020 34,535 0.00 26,379 1.31 No No
10/15/2020 34,535 -5.47 6,441 5.36 No No
09/30/2020 36,535 0.00 1,109 32.94 No No
09/15/2020 36,535 0.00 0 999.99 No No
08/31/2020 36,535 0.00 588 62.13 No No
08/14/2020 36,535 0.00 0 999.99 No No
07/31/2020 36,535 0.00 83 440.18 No No
07/15/2020 36,535 -0.27 35 999.99 No No

Koo

Share
New Message
Please login to post a reply